Project
Assessment of Chlamydia Vaccine
Summary: Developed a strategic positioning for a first-in-class chlamydia vaccine for the US market through primary and secondary research insights.
Categories:
Market Research, Strategy
Client
Industry:
Pharmaceuticals
Type:
For-Profit
Details
Year:
2024-2025
Program:
Daytime
Center:
HSM